Premarket movers: IRON reports Phase 3 trial success; EQPT raises outlook
IRON said its pivotal Phase 3 APOLLO trial of bitopertin met all primary and secondary endpoints. CLF reported earnings; EQPT raised its 2026 financial outlook, citing performance and customer demand. RCAT announced a proposed voluntary public purchase offer for Steyr Motors. APLD reported an insider purchase. JPM upgr